British outlets leaned on "‘Your devices could be at risk’". American outlets led with "A hotly debated lung cancer drug cut the risk of".
A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in China
CNBC · 31 May 2026
An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a late-stage trial, according to data released Sunday.
Guardian Business · 31 May 2026
Sentiment: 0.00
Read sourceCNBC · 31 May 2026
Sentiment: -0.50
Read sourceUS coverage was sharper than UK coverage on this story.
Why it matters: The same story, different frames. Editorial divergence reflects distinct national preoccupations.
